Hennion & Walsh Asset Management, Inc.

Position in OLMA — Olema Pharmaceuticals, Inc.

CIK 1861642 Parsippany, NJ

Position in OLMA

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$7,178,941

-$3,997,209 QoQ

Shares Held

481,485

+7.7% QoQ

Ownership

0.551%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Hennion & Walsh Asset Management, Inc. holds $181,506,492 across 60 Biotechnology names. OLMA ranks #7 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CELC	Celcuity Inc.	182,601	$20,842,078
2	COGT	Cogent Biosciences, Inc.	326,472	$12,565,907
3	JAZZ	Jazz Pharmaceuticals plc	49,352	$9,329,995
4	MIRM	Mirum Pharmaceuticals, Inc.	93,592	$8,646,028
5	DAWN	Day One Biopharmaceuticals, Inc.	367,134	$7,871,352
6	KALV	KalVista Pharmaceuticals, Inc.	375,995	$7,568,779
7	OLMA	Olema Pharmaceuticals, Inc. This page	481,485	$7,178,941
8	AXSM	Axsome Therapeutics, Inc.	36,633	$6,191,709

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,178,941	481,485	+7.7%	Shares	Sole	2026-05-13
2025-12-31	$11,176,150	447,046	+83.2%	Shares	Sole	2026-01-14
2025-09-30	$2,389,504	244,076	-1.8%	Shares	Sole	2025-10-22
2025-06-30	$1,058,788	248,542	+2.5%	Shares	Sole	2025-08-07
2025-03-31	$911,747	242,486	+14.2%	Shares	Sole	2025-04-10
2024-12-31	$1,237,394	212,246	+80.5%	Shares	Sole	2025-01-15
2024-09-30	$1,404,084	117,595	+34.7%	Shares	Sole	2024-10-22
2024-06-30	$944,715	87,312	—	Shares	Sole	2024-07-19
No filing history on record for this holder in this stock.